Of sorry, I got the name wrong. I wanted to say that the thing that Michael Harrop does is possible to do with little money because even the FDA seems to understand that it would be crazy to require clinical tests for approving individual donors.
On the other hand, if you would start a project for synthetic FMT capsules, I doubt that it could be done at that funding level in the current regulatory environment.
Of sorry, I got the name wrong. I wanted to say that the thing that Michael Harrop does is possible to do with little money because even the FDA seems to understand that it would be crazy to require clinical tests for approving individual donors.
On the other hand, if you would start a project for synthetic FMT capsules, I doubt that it could be done at that funding level in the current regulatory environment.